Clinical Trial

Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Previous studies have shown that compared with infertile women without adenomyosis, the clinical pregnancy rate, live birth rate and continuous pregnancy rate of women with adenomyosis significantly reduce, and the abortion rate obviously increased. However, these studies lack a definite classification of adenomyosis, so the true effect of adenomyosis with different severity on pregnancy outcomes are not clear. Our research team intends to collect clinical data of infertility patients with adenomyosis receiving IVF and the detailed classification of adenomyosis according to MUSA criteria. Finally, we can have an objective recognition of adenomyosis on pregnancy outcomes, which also bring benefits to evidence-based clinical practice.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-17; most recent amendment 2025-08-20.
Status change: Recruiting → Active, Not Recruiting 2025-08-06
Trial Details
NCT Number NCT06604091
Lead Sponsor The Second Hospital of Shandong University
Conditions Adenomyosis, in Vitro Fertilization
Enrollment 2,241 participants
Start Date 2024-06-30
Primary Completion 2027-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-21